Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Authors › Posts by Matthew Perrone

Matthew Perrone

Read the latest stories and analysis from Matthew Perrone.

Business

Lawmakers say FDA fell short in policing pharmacy

Matthew Perrone · April 16, 2013 9:07 pm
Business

Report finds lax oversight of specialty pharmacies

Matthew Perrone · April 16, 2013 1:03 am
Business

FDA reviewing heart risks of Glaxo diabetes pill

Matthew Perrone · April 12, 2013 9:16 pm
Business

Judges side with FDA in rejecting stem cell device

Matthew Perrone · March 22, 2013 6:43 pm
Business

FDA: Georgia pharmacy recalling all sterile drugs

Matthew Perrone · March 21, 2013 10:49 pm
Business

FDA warns of another compounding pharmacy recall

Matthew Perrone · March 20, 2013 9:20 pm
Business

FDA warns of mold in recalled specialty drugs

Matthew Perrone · March 18, 2013 9:11 pm
Business

FDA probes new pancreas risks with diabetes drugs

Matthew Perrone · March 14, 2013 8:18 pm
Business

Open gov’t groups: FDA redactions rules skirt law

Matthew Perrone · March 8, 2013 7:22 pm
Business

FDA panel sees risk in long-used osteoporosis drug

Matthew Perrone · March 5, 2013 10:44 pm
News

Republicans say FDA withholds key meningitis docs

Matthew Perrone · February 1, 2013 11:33 pm
Business

As America ages, senior care options flourish

Matthew Perrone · January 30, 2013 5:48 pm
Advertisement
  • ‹Previous page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • ›Next page
Page 10 of 13
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement